DEVELOPING A WELL-ROUNDED CLINICIAN
The 24-month specialty residency in pharmacotherapy at Barnes-Jewish Hospital is intended to train outstanding practitioners at the level of pharmacotherapy specialists. Our program is an ASHP-accredited PGY1 and PGY2 specialty-level program that is designed to give experiences in a broad range of clinical areas while allowing a resident to concentrate in a particular area of interest during the latter part of the program. Since the initiation of the pharmacotherapy program in 1998, our graduates have continually practiced at high levels in a variety of fields including cardiology, industry and research, internal medicine, patient safety, administration, emergency medicine, critical care, transplant, and infectious diseases.
Goals and objectives of a PGY1 and PGY2 residency will be incorporated into the two-year program. The residents will have an opportunity to work with Barnes-Jewish Hospital clinical pharmacists in a variety of settings including internal medicine, critical care (medical, surgical, neuroclinical, cardiac, and cardiothoracic), solid organ transplant, stem cell transplant, investigational drugs, and drug information. A longitudinal outpatient clinic experience is included in the second year of the Pharmacotherapy program.
In addition to clinical, teaching and research activities, residents will also be responsible for readying a paper for publication submission. Emphasis on preparation for attainment of Board Certification in Pharmacotherapy following graduation is included.
The Department participates in the ASHP residency matching program for the pharmacotherapy residency.
June 27, 2016
Doctor of Pharmacy degree and attainment of Missouri licensure
Number of Positions
One per year
Eli N. Deal, PharmD, BCPS
Program Director, Pharmacotherapy Residency
Department of Pharmacy 90-52-411
216 S. Kingshighway Blvd.
St. Louis, MO 63110
Pictured above (left to right): Pharmacotherapy Residency Program Director, Eli Deal, PharmD, BCPS; PGY1 Pharmacotherapy Resident, April Pottebaum, PharmD; PGY2 Pharmacotherapy Resident, Alyssa Thompson, PharmD.